Timmy3 Module Clinical Accuracy ISO 80601-2-56:2017 + A1 2018
TIMMY3 80601-2-56:2017 + A1 2018 Clinical Accuracy Study
1 other identifier
interventional
373
1 country
5
Brief Summary
The purpose of this document is to validate the clinical accuracy of the TIMMY3 thermometry module, integrated into host device CVSM, according to ISO 80601-2-56:2017 + A1 2018.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Feb 2024
5 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 19, 2023
CompletedFirst Posted
Study publicly available on registry
September 28, 2023
CompletedStudy Start
First participant enrolled
February 19, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 18, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 18, 2025
CompletedResults Posted
Study results publicly available
March 11, 2026
CompletedMarch 11, 2026
February 1, 2026
1.1 years
September 19, 2023
November 21, 2025
February 18, 2026
Conditions
Outcome Measures
Primary Outcomes (15)
Validate the Clinical Accuracy of the Timmy3 Thermometer Algorithm for Age Group >=5 Years - Clinical Bias
Clinical bias is the mean difference between the first device under test (DUT) output temperature (T1) and the corresponding reference clinical thermometer (TRCT) within the ISO-compliant analysis set and age group, calculated per ISO 80601-2-56:2017 + A1:2018 (refer to ISO formula \[2\]).
20-30 minutes
Validate the Clinical Accuracy of the Timmy3 Thermometer Algorithm for Age Group <1 Year - Clinical Bias
Clinical bias is the mean difference between the first device under test (DUT) output temperature (T1) and the corresponding reference clinical thermometer (TRCT) within the ISO-compliant analysis set and age group, calculated per ISO 80601-2-56:2017 + A1:2018 (refer to ISO formula \[2\]).
20-30 minutes
Validate the Clinical Accuracy of the Timmy3 Thermometer Algorithm for Age Group <3 Months - Clinical Bias
Clinical bias is the mean difference between the first device under test (DUT) output temperature (T1) and the corresponding reference clinical thermometer (TRCT) within the ISO-compliant analysis set and age group, calculated per ISO 80601-2-56:2017 + A1:2018 (refer to ISO formula \[2\]).
20-30 minutes
Validate the Clinical Accuracy of the Timmy3 Thermometer Algorithm for Age Group 3 Months to <1 Year - Clinical Bias
Clinical bias is the mean difference between the first device under test (DUT) output temperature (T1) and the corresponding reference clinical thermometer (TRCT) within the ISO-compliant analysis set and age group, calculated per ISO 80601-2-56:2017 + A1:2018 (refer to ISO formula \[2\]).
20-30 minutes
Validate the Clinical Accuracy of the Timmy3 Thermometer Algorithm for Age Group 1 Year to <5 Years - Clinical Bias
Clinical bias is the mean difference between the first device under test (DUT) output temperature (T1) and the corresponding reference clinical thermometer (TRCT) within the ISO-compliant analysis set and age group, calculated per ISO 80601-2-56:2017 + A1:2018 (refer to ISO formula \[2\]).
20-30 minutes
Validate the Clinical Accuracy of the Timmy3 Thermometer Algorithm for Age Group 5 Years to <18 Years - Clinical Bias
Clinical bias is the mean difference between the first device under test (DUT) output temperature (T1) and the corresponding reference clinical thermometer (TRCT) within the ISO-compliant analysis set and age group, calculated per ISO 80601-2-56:2017 + A1:2018 (refer to ISO formula \[2\]).
20-30 minutes
Validate the Clinical Accuracy of the Timmy3 Thermometer Algorithm for Age Group >=18 Years - Clinical Bias
Clinical bias is the mean difference between the first device under test (DUT) output temperature (T1) and the corresponding reference clinical thermometer (TRCT) within the ISO-compliant analysis set and age group, calculated per ISO 80601-2-56:2017 + A1:2018 (refer to ISO formula \[2\]).
20-30 minutes
Validate the Clinical Accuracy of the Timmy3 Thermometer Algorithm for Age Group >=5 Years - Limits of Agreement
Limits of Agreement represent the magnitude of potential disagreement between outputs of two thermometers and are defined as 2 × the standard deviation (SD) of the temperature differences (T1 - TRCT) within the ISO-compliant analysis set and age group, as specified in ISO 80601-2-56:2017 + A1:2018 (refer to ISO formulas \[3\] and \[4\]).
20-30 minutes
Validate the Clinical Accuracy of the Timmy3 Thermometer Algorithm for Age Group <1 Year - Limits of Agreement
Limits of Agreement represent the magnitude of potential disagreement between outputs of two thermometers and are defined as 2 × the standard deviation (SD) of the temperature differences (T1 - TRCT) within the ISO-compliant analysis set and age group, as specified in ISO 80601-2-56:2017 + A1:2018 (refer to ISO formulas \[3\] and \[4\]).
20-30 minutes
Validate the Clinical Accuracy of the Timmy3 Thermometer Algorithm for Age Group <3 Months - Limits of Agreement
Limits of Agreement represent the magnitude of potential disagreement between outputs of two thermometers and are defined as 2 × the standard deviation (SD) of the temperature differences (T1 - TRCT) within the ISO-compliant analysis set and age group, as specified in ISO 80601-2-56:2017 + A1:2018 (refer to ISO formulas \[3\] and \[4\]).
20-30 minutes
Validate the Clinical Accuracy of the Timmy3 Thermometer Algorithm for Age Group 3 Months to <1 Year - Limits of Agreement
Limits of Agreement represent the magnitude of potential disagreement between outputs of two thermometers and are defined as 2 × the standard deviation (SD) of the temperature differences (T1 - TRCT) within the ISO-compliant analysis set and age group, as specified in ISO 80601-2-56:2017 + A1:2018 (refer to ISO formulas \[3\] and \[4\]).
20-30 minutes
Validate the Clinical Accuracy of the Timmy3 Thermometer Algorithm for Age Group 1 Year to <5 Years - Limits of Agreement
Limits of Agreement represent the magnitude of potential disagreement between outputs of two thermometers and are defined as 2 × the standard deviation (SD) of the temperature differences (T1 - TRCT) within the ISO-compliant analysis set and age group, as specified in ISO 80601-2-56:2017 + A1:2018 (refer to ISO formulas \[3\] and \[4\]).
20-30 minutes
Validate the Clinical Accuracy of the Timmy3 Thermometer Algorithm for Age Group 5 Years to <18 Years - Limits of Agreement
Limits of Agreement represent the magnitude of potential disagreement between outputs of two thermometers and are defined as 2 × the standard deviation (SD) of the temperature differences (T1 - TRCT) within the ISO-compliant analysis set and age group, as specified in ISO 80601-2-56:2017 + A1:2018 (refer to ISO formulas \[3\] and \[4\]).
20-30 minutes
Validate the Clinical Accuracy of the Timmy3 Thermometer Algorithm for Age Group >=18 Years - Limits of Agreement
Limits of Agreement represent the magnitude of potential disagreement between outputs of two thermometers and are defined as 2 × the standard deviation (SD) of the temperature differences (T1 - TRCT) within the ISO-compliant analysis set and age group, as specified in ISO 80601-2-56:2017 + A1:2018 (refer to ISO formulas \[3\] and \[4\]).
20-30 minutes
Validate the Clinical Accuracy of the Timmy3 Thermometer Algorithm - Clinical Repeatability
Clinical repeatability is defined per ISO 80601-2-56:2017 + A1:2018 as the pooled within-subject standard deviation (SD) of triplicate device-under-test output temperatures for each anatomical site (refer to ISO formulas \[5\] and \[6\]). This outcome reports that SD as a single numeric value (°C); because it is a dispersion statistic (not a mean), no central-tendency measure applies. Higher SD indicates lower repeatability.
20-30 minutes
Study Arms (4)
Oral Temperature Measurement
EXPERIMENTALFebrile and non-febrile subjects aged 5 years or older.
Pediatric Axillary Temperature Measurement
EXPERIMENTALFebrile and non-febrile pediatric subjects \<1 year to \<18 years.
Adult Axillary Temperature Measurement
EXPERIMENTALFebrile and non-febrile adult subjects \>= 18 years old.
Rectal Temperature Measurement
EXPERIMENTALFebrile and non-febrile adult and pediatric subjects newborn and older.
Interventions
Connex Vital Signs Monitor with the Timmy3 Investigational module
Eligibility Criteria
You may qualify if:
- Study subjects (person who is having their temperature taken) must meet the following criteria to participate in this study:
- Subjects that are minors must provide assent to the clinical site's policy (if approved by Baxter) and/or the study sponsor's policy to participate in the study.
- Subject or the legally authorized representative (LAR) must sign the informed consent form in order for the subject to participate.
- Subject must be willing and able to comply with the study procedures.
- Age: normal weight (full-term) newborn to adult
- The study subject is in ambient temperature for at least 20 minutes prior to participating.
- The study subject is able to have their temperature taken for up to six minutes for multiple rounds of temperatures per anatomical site.
- The study subject is not physically or emotionally agitated/uncooperative.
- The study subject or legal guardian speaks/understands fluent English.
You may not qualify if:
- Study subjects (person who is having their temperature taken) are excluded if they meet any of the below criteria. Any subject that withdraws from the study will be replaced.
- The study subject has anatomical abnormalities that would affect temperature.
- The study subject has any known contraindication to oral, axillary, or rectal temperature measurements.
- The subject is not alert or unable to follow simple commands such as closing one's mouth completely around the probe if an oral reference temperature is being taken.
- The study subject has consumed food or drink, or smoked, within the last 20 minutes. The subject may be included if they wait 20 minutes prior to taking oral temperature.
- The study subject has engaged in strenuous or semi-strenuous activity within the last twenty minutes (i.e., running, weightlifting, etc.).
- Subject has taken antipyretics (Aspirin, acetaminophen, ibuprofen) in the preceding 120 minutes.
- Subjects has medical conditions such as inflammation at the MEASURING SITE (Barbiturates, thyroid preparations, antipsychotics, recent immunizations).
- Neutropenic immunocompromised patients, in whom rectal manipulation may seed the blood with bacteria.
- Note: The study subject will be excluded if the reference temperature does not stabilize after the 3 -5 minute monitoring time.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (5)
First Georgia Physicians Group
Fayetteville, Georgia, 30214, United States
Mankato Clinic
Mankato, Minnesota, 56001, United States
John R. Oishei Children's Hospital
Buffalo, New York, 14203, United States
Medical University of South Carolina
Charleston, South Carolina, 29425, United States
Forest Lane Pediatrics
Dallas, Texas, 75230, United States
Results Point of Contact
- Title
- Baxter Clinical Trials Disclosure Call Center
- Organization
- Baxter Healthcare
Study Officials
- STUDY DIRECTOR
Eric Fernandez, M.D.
Baxter Healthcare Corporation
Publication Agreements
- PI is Sponsor Employee
- No
- Restriction Type
- OTHER
- Restrictive Agreement
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SEQUENTIAL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 19, 2023
First Posted
September 28, 2023
Study Start
February 19, 2024
Primary Completion
March 18, 2025
Study Completion
March 18, 2025
Last Updated
March 11, 2026
Results First Posted
March 11, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share